Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.

Krenzien F, ElKhal A, Quante M, Rodriguez Cetina Biefer H, Hirofumi U, Gabardi S, Tullius SG.

Transplantation. 2015 Nov;99(11):2258-68. doi: 10.1097/TP.0000000000000842. Review.

2.

Impact of immunosenescence on transplant outcome.

Heinbokel T, Hock K, Liu G, Edtinger K, Elkhal A, Tullius SG.

Transpl Int. 2013 Mar;26(3):242-53. doi: 10.1111/tri.12013. Epub 2012 Nov 29. Review.

3.

Need for optimized immunosuppression in elderly kidney transplant recipients.

Lehner LJ, Staeck O, Halleck F, Liefeldt L, Bamoulid J, Budde K.

Transplant Rev (Orlando). 2015 Oct;29(4):237-9. doi: 10.1016/j.trre.2015.08.001. Epub 2015 Aug 15. Review.

PMID:
26411381
4.

Immunosenescence and organ transplantation.

Heinbokel T, Elkhal A, Liu G, Edtinger K, Tullius SG.

Transplant Rev (Orlando). 2013 Jul;27(3):65-75. doi: 10.1016/j.trre.2013.03.001. Epub 2013 Apr 30. Review.

5.

Immunosuppression of the elderly kidney transplant recipient.

Danovitch GM, Gill J, Bunnapradist S.

Transplantation. 2007 Aug 15;84(3):285-91. Review.

PMID:
17700150
6.

The spectrum of complications of immunosuppression: is the time right for hand transplantation?

Brenner MJ, Tung TH, Jensen JN, Mackinnon SE.

J Bone Joint Surg Am. 2002 Oct;84-A(10):1861-70. Review. No abstract available.

PMID:
12377920
7.

Understanding alterations in drug handling with aging: a focus on the pharmacokinetics of maintenance immunosuppressants in the elderly.

Gabardi S, Tullius SG, Krenzien F.

Curr Opin Organ Transplant. 2015 Aug;20(4):424-30. doi: 10.1097/MOT.0000000000000220. Review.

PMID:
26126198
8.

Cancer and mTOR Inhibitors in Transplant Recipients.

de Fijter JW.

Transplantation. 2017 Jan;101(1):45-55. doi: 10.1097/TP.0000000000001447. Review.

PMID:
27547865
9.

Some observations on prope tolerance.

Calne R, Watson CJ.

Curr Opin Organ Transplant. 2011 Aug;16(4):353-8. doi: 10.1097/MOT.0b013e328348b44c. Review.

PMID:
21666472
10.

Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.

Smedman TM, Line PD, Guren TK, Dueland S.

Acta Oncol. 2018 Oct;57(10):1414-1418. doi: 10.1080/0284186X.2018.1479069. Epub 2018 Jun 18. Review. No abstract available.

PMID:
29912605
11.

The need for minimization strategies: current problems of immunosuppression.

Bamoulid J, Staeck O, Halleck F, Khadzhynov D, Brakemeier S, Dürr M, Budde K.

Transpl Int. 2015 Aug;28(8):891-900. doi: 10.1111/tri.12553. Epub 2015 Mar 18. Review.

12.

Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols.

Aiello FB, Furian L, Marino S, Marchini F, Cardillo M, De Fazio N, Rigotti P, Valente M.

Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):1001-7.

PMID:
20074463
13.

[Modern immunosuppression after solid organ transplantation].

Beimler J, Morath C, Zeier M.

Internist (Berl). 2014 Feb;55(2):212-22. doi: 10.1007/s00108-013-3411-8. German.

PMID:
24518922
14.

New immunosuppressive strategies and the risk of infection.

Mueller NJ.

Transpl Infect Dis. 2008 Dec;10(6):379-84. doi: 10.1111/j.1399-3062.2008.00346.x. Epub 2008 Sep 21. Review.

PMID:
18811628
15.

Future trends in organ transplant recipients--important issues for dermatologists.

Zecher D, Steiger J.

Curr Probl Dermatol. 2012;43:71-80. doi: 10.1159/000335153. Epub 2012 Feb 17. Review.

PMID:
22377921
16.

Steroid or calcineurin inhibitor-sparing immunosuppressive protocols.

Grinyó JM, Cruzado JM.

Contrib Nephrol. 2005;146:30-42. Review.

PMID:
15567918
17.

Generic immunosuppression in solid organ transplantation: a Canadian perspective.

Harrison JJ, Schiff JR, Coursol CJ, Daley CJ, Dipchand AI, Heywood NM, Keough-Ryan TM, Keown PA, Levy GA, Lien DC, Wichart JR, Cantarovich M.

Transplantation. 2012 Apr 15;93(7):657-65. doi: 10.1097/TP.0b013e3182445e9d. Review.

PMID:
22267158
18.

[The mechanisms of chronic kidney damage in renal transplant and their possible reversibility].

Schena FP, Maiorano A, Rossini M.

G Ital Nefrol. 2008 Nov-Dec;25 Suppl 44:S11-4. Italian.

PMID:
19048580
19.

Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.

Khanmoradi K, Knorr JP, Feyssa EL, Parsikia A, Jawa P, Dinh DB, Campos S, Zaki RF, Ortiz JA.

Exp Clin Transplant. 2013 Jun;11(3):222-8. doi: 10.6002/ect.2012.0211. Epub 2013 Feb 22.

20.

Supplemental Content

Support Center